Skip to main content

Table 1 Baseline characteristics of all patients with COVID-19

From: Effect of hypertension on outcomes of adult inpatients with COVID-19 in Wuhan, China: a propensity score–matching analysis

  Survivor(n = 176) Non-survivor(n = 50) P-value
Males (%) 82 (46.60%) 31 (62%) 0.077
Age (years) 49.93 (15.35) 67.82 (15.73) < 0.001
Onset time (day) 7.16 (3.86) 6.54 (3.71) 0.619
Hypertension (%) 47 (26.70%) 37 (74%) < 0.001
T2DM (%) 28 (15.91%) 17 (34%) 0.008
CHD (%) 6 (3.41%) 7 (14%) 0.010
COPD (%) 3 (1.70%) 3 (6.00%) 0.124
WBC (109) 5.15 (3.71–6.44) 5.73 (4.18–7.95) 0.078
N (109) 3.34 (2.34–4.76) 4.32 (2.97–7.05) 0.002
L (109) 1.10 (0.75–1.52) 0.66 (0.46–0.92) < 0.001
N/L 2.98 (1.70–5.51) 6.18 (3.58–12.78) < 0.001
ALT (U/L) 19.70 (13.60–33.65) 21.05 (14.33–29.48) 0.819
AST (U/L) 21.35 (17.20–32.95) 31.50 (22.40–44.33) 0.001
ALB (g/L) 39.24 (5.25) 35.55 (4.30) < 0.001
sCr (μmol/L) 64.90 (52.20–75.93) 76.00 (58.00–109.20) 0.003
BUN (mmol/L) 3.97 (3.13–5.25) 6.60 (4.60–10.58) < 0.001
CRP (mg/dL) 1.52 (0.28–5.03) 6.10 (3.53–8.84) < 0.001
D-dimer (μg/mL) 0.56 (0.28–1.28) 6.21 (1.27–19.73) < 0.001
  1. Abbreviations: Onset time, time from onset to admission (days); T2DM Type 2 diabetes mellitus; CHD Coronary heart disease; COPD Chronic obstructive pulmonary disease; WBC White blood cells; L Lymphocyte count; N Neutrophil count; N/L Ratio of neutrophils to lymphocytes; ALT alanine transaminase; AST Aspartate aminotransferase; ALB Serum albumin; sCr Serum creatinine; BUN Blood urea nitrogen; CRP C-reactive protein